The relationship between headache-attributed disability and lost productivity: 3 Attack frequency is the dominating variable

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

The relationship between headache-attributed disability and lost productivity : 3 Attack frequency is the dominating variable. / Husøy, Andreas; Katsarava, Zaza; Steiner, Timothy J.

I: Journal of Headache and Pain, Bind 24, Nr. 1, 7, 2023.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Husøy, A, Katsarava, Z & Steiner, TJ 2023, 'The relationship between headache-attributed disability and lost productivity: 3 Attack frequency is the dominating variable', Journal of Headache and Pain, bind 24, nr. 1, 7. https://doi.org/10.1186/s10194-023-01546-9

APA

Husøy, A., Katsarava, Z., & Steiner, T. J. (2023). The relationship between headache-attributed disability and lost productivity: 3 Attack frequency is the dominating variable. Journal of Headache and Pain, 24(1), [7]. https://doi.org/10.1186/s10194-023-01546-9

Vancouver

Husøy A, Katsarava Z, Steiner TJ. The relationship between headache-attributed disability and lost productivity: 3 Attack frequency is the dominating variable. Journal of Headache and Pain. 2023;24(1). 7. https://doi.org/10.1186/s10194-023-01546-9

Author

Husøy, Andreas ; Katsarava, Zaza ; Steiner, Timothy J. / The relationship between headache-attributed disability and lost productivity : 3 Attack frequency is the dominating variable. I: Journal of Headache and Pain. 2023 ; Bind 24, Nr. 1.

Bibtex

@article{bfe5c15c6ddc49ecb305ada7c802e4be,
title = "The relationship between headache-attributed disability and lost productivity: 3 Attack frequency is the dominating variable",
abstract = "Background: In an earlier paper, we examined the relationship between headache-attributed disability, measured as proportion of time in ictal state, and lost productivity. In a linear model, we found positive and significant associations with lost paid worktime, lost household worktime and total lost productivity (paid + household), but with high variance, which was increased when headache intensity was introduced as a factor. We speculated that analyses based on headache frequency alone as the independent variable, eliminating both the subjectivity of intensity estimates and the uncertainties of duration, might show stronger associations. Methods: Focusing on migraine, we used individual participant data from 16 countries surveyed either in population-based studies or in the Eurolight project. These data included frequency (headache days/month), usual attack duration (hours), usual headache intensity (“not bad”, “quite bad”, “very bad”) and lost productivity from paid and household work according to enquiries using the Headache-Attributed Lost Time (HALT) questionnaire. We used multiple linear regressions, calculating regression equations along with unstandardized and standardized regression coefficients. We made line and bar charts to visualize relationships. Results: Both frequency and intensity were significant predictors of lost productivity in all multiple linear regressions, but duration was a non-significant predictor in several of the regressions. Predicted productivity in paid work decreased among males by 0.75–0.85 days/3 months for each increase of 1 headache day/month, and among females by 0.34–0.53 days/3 months. In household chores, decreases in productivity for each added day/month of headache were more similar (0.67–0.87 days/3 months among males, 0.83–0.89 days/3 months among females). Visualizations showed that the impact of duration varied little across the range of 2–24 h. The standardized regression coefficients demonstrated that frequency was a much better predictor of lost productivity than intensity or duration. Conclusion: In the relationship between migraine-attributed impairment (symptom burden) and lost productivity, frequency (migraine days/month) is the dominating variable – more important than headache intensity and far more important than episode duration. This has major implications for current practice in headache care and for health policy and health-resource investment. Preventative drugs, grossly underutilized in current practice, offer a high prospect of economic benefit (cost-saving), but new preventative drugs are needed with better efficacy and/or tolerability.",
keywords = "Association analysis, Disability, Global Campaign against Headache, Headache frequency, Health economics, Health policy, Lost productivity, Migraine, Migraine preventative drugs",
author = "Andreas Hus{\o}y and Zaza Katsarava and Steiner, {Timothy J.}",
note = "Publisher Copyright: {\textcopyright} 2023, The Author(s).",
year = "2023",
doi = "10.1186/s10194-023-01546-9",
language = "English",
volume = "24",
journal = "Journal of Headache and Pain",
issn = "1129-2369",
publisher = "SpringerOpen",
number = "1",

}

RIS

TY - JOUR

T1 - The relationship between headache-attributed disability and lost productivity

T2 - 3 Attack frequency is the dominating variable

AU - Husøy, Andreas

AU - Katsarava, Zaza

AU - Steiner, Timothy J.

N1 - Publisher Copyright: © 2023, The Author(s).

PY - 2023

Y1 - 2023

N2 - Background: In an earlier paper, we examined the relationship between headache-attributed disability, measured as proportion of time in ictal state, and lost productivity. In a linear model, we found positive and significant associations with lost paid worktime, lost household worktime and total lost productivity (paid + household), but with high variance, which was increased when headache intensity was introduced as a factor. We speculated that analyses based on headache frequency alone as the independent variable, eliminating both the subjectivity of intensity estimates and the uncertainties of duration, might show stronger associations. Methods: Focusing on migraine, we used individual participant data from 16 countries surveyed either in population-based studies or in the Eurolight project. These data included frequency (headache days/month), usual attack duration (hours), usual headache intensity (“not bad”, “quite bad”, “very bad”) and lost productivity from paid and household work according to enquiries using the Headache-Attributed Lost Time (HALT) questionnaire. We used multiple linear regressions, calculating regression equations along with unstandardized and standardized regression coefficients. We made line and bar charts to visualize relationships. Results: Both frequency and intensity were significant predictors of lost productivity in all multiple linear regressions, but duration was a non-significant predictor in several of the regressions. Predicted productivity in paid work decreased among males by 0.75–0.85 days/3 months for each increase of 1 headache day/month, and among females by 0.34–0.53 days/3 months. In household chores, decreases in productivity for each added day/month of headache were more similar (0.67–0.87 days/3 months among males, 0.83–0.89 days/3 months among females). Visualizations showed that the impact of duration varied little across the range of 2–24 h. The standardized regression coefficients demonstrated that frequency was a much better predictor of lost productivity than intensity or duration. Conclusion: In the relationship between migraine-attributed impairment (symptom burden) and lost productivity, frequency (migraine days/month) is the dominating variable – more important than headache intensity and far more important than episode duration. This has major implications for current practice in headache care and for health policy and health-resource investment. Preventative drugs, grossly underutilized in current practice, offer a high prospect of economic benefit (cost-saving), but new preventative drugs are needed with better efficacy and/or tolerability.

AB - Background: In an earlier paper, we examined the relationship between headache-attributed disability, measured as proportion of time in ictal state, and lost productivity. In a linear model, we found positive and significant associations with lost paid worktime, lost household worktime and total lost productivity (paid + household), but with high variance, which was increased when headache intensity was introduced as a factor. We speculated that analyses based on headache frequency alone as the independent variable, eliminating both the subjectivity of intensity estimates and the uncertainties of duration, might show stronger associations. Methods: Focusing on migraine, we used individual participant data from 16 countries surveyed either in population-based studies or in the Eurolight project. These data included frequency (headache days/month), usual attack duration (hours), usual headache intensity (“not bad”, “quite bad”, “very bad”) and lost productivity from paid and household work according to enquiries using the Headache-Attributed Lost Time (HALT) questionnaire. We used multiple linear regressions, calculating regression equations along with unstandardized and standardized regression coefficients. We made line and bar charts to visualize relationships. Results: Both frequency and intensity were significant predictors of lost productivity in all multiple linear regressions, but duration was a non-significant predictor in several of the regressions. Predicted productivity in paid work decreased among males by 0.75–0.85 days/3 months for each increase of 1 headache day/month, and among females by 0.34–0.53 days/3 months. In household chores, decreases in productivity for each added day/month of headache were more similar (0.67–0.87 days/3 months among males, 0.83–0.89 days/3 months among females). Visualizations showed that the impact of duration varied little across the range of 2–24 h. The standardized regression coefficients demonstrated that frequency was a much better predictor of lost productivity than intensity or duration. Conclusion: In the relationship between migraine-attributed impairment (symptom burden) and lost productivity, frequency (migraine days/month) is the dominating variable – more important than headache intensity and far more important than episode duration. This has major implications for current practice in headache care and for health policy and health-resource investment. Preventative drugs, grossly underutilized in current practice, offer a high prospect of economic benefit (cost-saving), but new preventative drugs are needed with better efficacy and/or tolerability.

KW - Association analysis

KW - Disability

KW - Global Campaign against Headache

KW - Headache frequency

KW - Health economics

KW - Health policy

KW - Lost productivity

KW - Migraine

KW - Migraine preventative drugs

U2 - 10.1186/s10194-023-01546-9

DO - 10.1186/s10194-023-01546-9

M3 - Journal article

C2 - 36782131

AN - SCOPUS:85147913103

VL - 24

JO - Journal of Headache and Pain

JF - Journal of Headache and Pain

SN - 1129-2369

IS - 1

M1 - 7

ER -

ID: 371688647